Jiaren Zhou

Zhuji Central Hospital, Zhuji, 311800, China
Author    Correspondence author
International Journal of Clinical Case Reports, 2024, Vol. 14, No. 2   
Received: 29 Mar., 2024    Accepted: 30 Apr., 2024    Published: 12 May, 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Targeted therapy for specific genetic variations in cancer represents an important breakthrough in the field of modern medicine. Targeted therapy provides more effective and precise treatment methods by intervening with specific molecular targets or communication pathways in cancer cells. Especially in cancer treatment driven by specific genetic variations, targeted therapy has achieved significant success, significantly improving the survival rate and quality of life of patients. Targeted therapy emphasizes the crucial role of molecular diagnosis and biomarkers, encouraging deeper research into the molecular mechanisms of diseases in order to find new therapeutic targets. This review discusses the role of genetic variation in cancer and the principles and applications of targeted therapy. It combines relevant cases to deeply explore the importance of targeted therapy for specific genetic variations in cancer, providing profound insights for better response to cancer and improving treatment effectiveness, and promoting progress in the medical field.

Cancer; Genetic variation; Targeted therapy; Personalized medicine; Case analysis